Early prediction of chronic lung disease by tracheal aspirate cytology in ventilated newborns

Citation
K. Smets et al., Early prediction of chronic lung disease by tracheal aspirate cytology in ventilated newborns, EUR J PED, 158(3), 1999, pp. 234-237
Citations number
17
Categorie Soggetti
Pediatrics,"Medical Research General Topics
Journal title
EUROPEAN JOURNAL OF PEDIATRICS
ISSN journal
03406199 → ACNP
Volume
158
Issue
3
Year of publication
1999
Pages
234 - 237
Database
ISI
SICI code
0340-6199(199903)158:3<234:EPOCLD>2.0.ZU;2-1
Abstract
We assessed the specificity of squamous metaplasia in tracheal aspirates of 69 ventilated newborns (gestational age 25-41 weeks) between days 3 and 7 of life for prediction of chronic lung disease (CLD). CLD was diagnosed whe n the patient was still requiring ventilation or supplementary oxygen at th e postconceptional age of 36 weeks (or postnatal age of 28 days for babies born after 32 weeks gestation) and showed X-ray changes compatible with CLD . In the total population the presence of squamous metaplasia had a sensiti vity of 59% and a specificity of 74% for the early diagnosis of CLD. The co mbination of squamous metaplasia and very lon birth weight (VLBW) had a muc h higher specificity (94%), but a lower sensitivity (45%). Our results show that the presence of sqaumous metaplasia in VLBW babies during the Ist wee k of life predicts development of CLD with a specificity of 94% and may be helpful for entering patients into early treatment protocols or trials when a high risk population needs to be identified. as sensitivity of this appr oach is only 45%. further studies are needed to evaluate the predictive val ue of the combination of cytology with other markers in tracheal aspirate s pecimens. Conclusion The presence of squamous metaplasia in tracheal aspirates of VLB W babies between days 3 and 7 of life is significantly associated with the development of chronic lung disease. Simple microscopic evaluation of fresh tracheal aspirates enables us to identify patients at high risk of CLD at a very early stage.